Dec 20 (Reuters) - Safe SA ALSAF.PA :
* ANNOUNCES FIRST CLINICAL BENEFITS AT 3 MONTHS AND GLOBAL
LAUNCH
OF SYCAMORE
* 65% PAIN REDUCTION (ODI & VAS SCALES)
* GLOBAL LAUNCH IN EARLY JANUARY 2022
* 510K EXPECTED IN 2022
* EVALUATION GROUP GAVE VERY SATISFACTORY CONCLUSIONS ON NEW
PRODUCT WITH A REDUCTION OF PAIN OBSERVED IN POST-SURGERY OF
ABOUT 65% ACCORDING TO PAIN SCALES ODI AND VAS
Source text for Eikon: urn:newsml:reuters.com:*:nGNEb14PlD
Further company coverage: ALSAF.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))